scholarly journals Giant magnetoresistive biochip for DNA detection and HPV genotyping

2008 ◽  
Vol 24 (1) ◽  
pp. 99-103 ◽  
Author(s):  
Liang Xu ◽  
Heng Yu ◽  
Michael S. Akhras ◽  
Shu-Jen Han ◽  
Sebastian Osterfeld ◽  
...  
Keyword(s):  
2020 ◽  
Vol 23 (11) ◽  
pp. 28-33
Author(s):  
S.P. Yatsentyuk ◽  
◽  
D.A. Rudnyayev ◽  
Yu.I. Pobolelova ◽  
M.S. Krasnikova ◽  
...  

2011 ◽  
Vol 1 (4) ◽  
pp. 325-333
Author(s):  
Filiz Kuralay ◽  
Hakan Karadeniz ◽  
Mihrican Muti ◽  
Arzum Erdem

2020 ◽  
Vol 47 (5) ◽  
pp. 314-320 ◽  
Author(s):  
D. Allen Roberts ◽  
Stephen E. Hawes ◽  
Mame D. Bousso Bao ◽  
Anna Julienne Ndiaye ◽  
Daouda Gueye ◽  
...  

1992 ◽  
Vol 30 (4) ◽  
pp. 237-243 ◽  
Author(s):  
I. Madinier ◽  
A. Doglio ◽  
L. Cagnon ◽  
J.C. Lefe`bvre ◽  
R.A. Monteil

BMC Cancer ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Stanie Gaete ◽  
Aviane Auguste ◽  
Bernard Bhakkan ◽  
Jessica Peruvien ◽  
Cecile Herrmann-Storck ◽  
...  

Abstract Background Cervical cancer is the fourth cancer worldwide. The Human Papilloma Virus is responsible for 99% of the cases but the distribution of its genotypes varies among populations. We aimed to identify HPV genotypes distribution in women with grade 2/3 cervical intraepithelial dysplasia or invasive cervical cancer in Guadeloupe, a French Caribbean territory with a population mainly of African descent. Methods We used paraffin-embedded tumors for viral DNA extraction from women diagnosed between 2014 and 2016 and identified by the population-based cancer registry. The HPV Genotyping was performed with the InnoLIPA HPV Genotyping Extra kit®. Results Overall, 213 samples out of the 321 eligible records were analyzed. The HPV status was positive for 94% of the cases. The five most common oncogenic HPV genotypes were HPV31 (47%), HPV33 (38%), HPV16 (32%), HPV44 (31%) and HPV26 (28%). HPV18 was found in only in 5% of the cases. Among the studied cases, 94% had multiple infections. More than 60% of single infections were HPV16-related, accounting for 35% of HPV16 infections. Conclusions These results show a different distribution of oncogenic HPVs in Guadeloupe with “31 >  33 > 16” and a high frequency of multiple infections. Despite a lower coverage, the nine-valent vaccine is nevertheless adequate.


2021 ◽  
Author(s):  
Quentin Mauvisseau ◽  
David Halfmaerten ◽  
Sabrina Neyrinck ◽  
Alfred Burian ◽  
Rein Brys

Sign in / Sign up

Export Citation Format

Share Document